CytoMed, a Singapore Biotech, Revolutionizes Cancer Treatment Using Donor Immune Cells
In Singapore, one biotech company is changing how we approach cancer treatment. CytoMed Therapeutics (NASDAQ: GDTC), just launched its ANGELICA clinical trial, to fundamentally change how we make... Read More
Singapore
EDDID Launches AI-Driven Quantitative Arbitrage Platform for Singapore Futures Fund
EDDID Financial, a subsidiary of Hong Kong–based EDDID Group, has officially launched its AI-Powered Quantitative Arbitrage Platform for the Singapore Futures Fund, marking a major... Read More